CAR T Cells Tied to Longer Remission, More Care Days in FL
Summary
Researchers compare survival and time spent in healthcare with CAR T cells vs bispecific antibodies in patients with relapsed or refractory follicular lymphoma treated in the third line or later.
Description from Medscape.
Who is covering this
-
CAR T Cells Tied to Longer Remission, More Care Days in FL
Researchers compare survival and time spent in healthcare with CAR T cells vs bispecific antibodies in patients with relapsed or refractory follicular lymphoma treated in the third line or later.
Comments
Comments need JavaScript.